Quest Diagnostics, a leader in diagnostic information services, including advanced diagnostics for brain health, announced it plans to offer laboratory testing based on the Lumipulse G pTau 217/ß-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test …

Study results show that having an extremely aged brain nearly triples a person's risk of dying during a roughly 15-year period. Adobe stock/Hea;thDay July 10 (UPI) -- They say age is all in your mind -- and that might literally be true, a new study …

THEY aid us in almost every daily task and are among the most intricate tools we possess. But your hands can also provide a window into your health - offering up early signs of all sorts of conditions including Alzheimer's, heart disease and cancer. 4 …

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one that researchers are exploring with gusto. In a study published in 2023, scientists found that using sleeping pills to …

Fiona Phillips and her husband Martin Frizell has detailed the worrying time they feared their sons Nathaniel, 26, and Mackenzie, 23, could inherit Alzheimer's. The former GMTV host, 64, was diagnosed with the progressive brain disorder in 2022 at the …

Eli Lilly has won a green light from the FDA for new dosing for its Alzheimer's disease therapy Kisunla, which carries a reduced risk of adverse reactions that may have held back its uptake in the market. The US regulator has approved a label update …

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a new dosing regimen of the drug with an improved safety profile. The new recommended regimen for Kisunla features a more gradual …

Posted Wed, Jul 9, 2025 at 11:50 am ET|Updated Wed, Jul 9, 2025 at 12:37 pm ET AVON, CT — Like many folks, Avon resident Erin Mahoney has felt the impact of Alzheimer's disease, which in 2018 took away her mother after a long battle. But for Mahoney, …

A scan that can detect Alzheimer’s disease before memory loss begins is now available in the UAE for the first time. The amyloid PET scan, recently launched at Cleveland Clinic Abu Dhabi, is a milestone in the region’s fight against neurodegenerative …

(MENAFN- PR Newswire) Building on the positive results of Phase 2 clinical trials in PSP and ALS, Transposon plans to initiate a Phase 2 clinical trial of TPN-101 for the treatment of Alzheimer's disease in Q4 2025 Concurrently, Transposon is advancing …